Pure Global
NCT00711022

Study on ASTRA TECH Implant System, OsseoSpeed™ Implants in Patients Missing All Teeth in the Upper Jaw, Restored With Provisional Teeth Within 24 Hours

An Open, Prospective, Multicenter Study to Evaluate the Outcome of ASTRA TECH Implant System, OsseoSpeed™ Implants, in Patients With Totally Edentulous Maxillas and Poor Bone Quality and Quantity in an Immediate Loading Protocol.
Dentsply Sirona Implants and Consumables·ClinicalTrials.gov·device·Device trialCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Jaw, Edentulous
Drug/Device/Intervention
ASTRA TECH Implant System, OsseoSpeed™, all dimensions.
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Dentsply Sirona Implants and Consumables
Location
Chicago,Uppsala, Sweden,United States of America
Timeline & enrollment
Phase
N/A
Start date
May 01, 2005
End date
Mar 01, 2012
Enrollment
51 participants
Primary outcome

Implant Survival Rate

Summary

The purpose of the study is to evaluate ASTRA TECH Implant System, OsseoSpeed™ implants, in
 patients with totally edentulous upper jaws and poor bone quality and quantity, when
 provisional artificial teeth are attached within 24 hours. The primary objective is to
 investigate implant survival rate.

ICD-10 classifications
Dislocation of jawMottled teethDisorder of gingiva and edentulous alveolar ridge, unspecifiedOther disorders of gingiva and edentulous alveolar ridgeOther specified disorders of gingiva and edentulous alveolar ridge
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT00711022
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT00711022 through Pure Global AI's free database. This phase not specified trial is sponsored by Dentsply Sirona Implants and Consumables and is currently Completed. The study focuses on Jaw, Edentulous. Target enrollment is 51 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.